AVTR Avantor Inc

$14.10

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

In the upcoming earnings report for Avantor (AVTR), investors will be keenly observing how the company's strategic initiatives have translated into financial performance, especially given its market cap of approximately $9.27 billion. With an EPS estimate of $0.25, slightly above the whisper number of $0.24, there is cautious optimism about Avantor's ability to meet or exceed expectations. The revenue estimate stands at $1.67 billion, which will be a critical indicator of the company's growth trajectory in the absence of recent news. As Avantor continues to navigate a competitive landscape, its ability to leverage its scale and operational efficiencies will be pivotal in maintaining investor confidence and achieving sustainable growth.

Updated On 10/6/2025

About Avantor Inc

Avantor, Inc. provides products and services to clients in the biopharmaceutical, healthcare, education and government, advanced technologies and applied materials industries in America, Europe, Asia, the Middle East and Africa. The company is headquartered in Radnor, Pennsylvania.

Website: https://www.avantorsciences.com

Sector
LIFE SCIENCES
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1722482
Address
BUILDING ONE, SUITE 200, 100 MATSONFORD ROAD, RADNOR, PA, US
Valuation
Market Cap
$10.29B
P/E Ratio
14.52
PEG Ratio
nan
Price to Book
1.73
Performance
EPS
$1.04
Dividend Yield
—
Profit Margin
10.50%
ROE
12.70%
Technicals
50D MA
$16.61
200D MA
$21.63
52W High
$28.00
52W Low
$13.80
Fundamentals
Shares Outstanding
681M
Target Price
$22.35
Beta
1.24

AVTR EPS Estimates vs Actual

● Estimated
● Actual

AVTR News & Sentiment

Sep 25, 2025 • Benzinga SOMEWHAT-BULLISH
SoCalBio Investor Conference Sessions to Spotlight Bioscience Workforce Development, Technology Transfer, and AI-Driven Innovation
LOS ANGELES, Sept. 25, 2025 ( GLOBE NEWSWIRE ) -- The Southern California Biomedical Council ( SoCalBio ) today announced the final lineup of expert panels for its 27th Annual Investor & Partnership Conference, taking place October 1-2 at the Hyatt Regency Newport Beach.
Sep 16, 2025 • Benzinga BULLISH
SoCalBio Investor Conference to Showcase 22 Emerging Bioscience Startups; Leading VC and Angel Investors Confirmed
LOS ANGELES, Sept. 16, 2025 ( GLOBE NEWSWIRE ) -- The Southern California Biomedical Council ( SoCalBio ) today unveiled the updated lineup of 22 emerging bioscience companies and confirmed investors for its 27th Annual Investor & Partnership Conference, taking place October 1-2 at the Hyatt ...
Sep 09, 2025 • Benzinga SOMEWHAT-BULLISH
SoCalBio Investor Conference Kicks Off October 1st with Keynote by SetPoint Medical CEO
LOS ANGELES, Sept. 09, 2025 ( GLOBE NEWSWIRE ) -- The Southern California Biomedical Council ( SoCalBio ) today announced the agenda, speakers, and presenting companies for its 27th Annual Investor & Partnership Conference, which will be held October 1-2 at the Hyatt Regency Newport Beach.
Aug 25, 2025 • Benzinga SOMEWHAT-BULLISH
Biobanking Market is expected to generate a revenue of USD 2.11 Billion by 2031, Globally, at 9.89% CAGR: Verified Market Research®
Lewes, Delaware, Aug. 25, 2025 ( GLOBE NEWSWIRE ) -- The Global Biobanking Market Size is projected to grow at a CAGR of 9.89% from 2024 to 2031, according to a new report published by Verified Market Research®.
Aug 16, 2025 • CNBC SOMEWHAT-BULLISH
Engine Capital takes a stake in Avantor. Activist sees several ways to create value
Engine believes that Avantor's significant underperformance is a consequence of self-inflicted mistakes rooted in a flawed leadership team and framework.
Aug 11, 2025 • Benzinga SOMEWHAT-BULLISH
Why Is Avantor Stock Surging Monday? - Avantor ( NYSE:AVTR )
Engine estimates Avantor's strategic value at $17-$19 per share, a 50% premium. LSS margins trail Thermo Fisher's comparable division by 450 basis points. This simple system has nailed 1,000+ post-earnings winners. Get in before Q3 trades take off → Avantor Inc.
Sentiment Snapshot

Average Sentiment Score:

0.151
50 articles with scored sentiment

Overall Sentiment:

Bullish

AVTR Reported Earnings

Apr 24, 2025
Mar 31, 2025 (Pre market)
-0.0 Surprise
  • Reported EPS: $0.23
  • Estimate: $0.23
  • Whisper: —
  • Surprise %: -0.7%
Feb 12, 2025
Dec 31, 2024 (Pre market)
0.01 Surprise
  • Reported EPS: $0.27
  • Estimate: $0.26
  • Whisper: —
  • Surprise %: 4.5%
Oct 25, 2024
Sep 30, 2024 (Pre market)
0.01 Surprise
  • Reported EPS: $0.26
  • Estimate: $0.25
  • Whisper: —
  • Surprise %: 4.0%
Jul 26, 2024
Jun 30, 2024 (Pre market)
0.02 Surprise
  • Reported EPS: $0.25
  • Estimate: $0.23
  • Whisper: —
  • Surprise %: 8.7%
Apr 26, 2024
Mar 31, 2024 (Pre market)
0.02 Surprise
  • Reported EPS: $0.22
  • Estimate: $0.20
  • Whisper: —
  • Surprise %: 10.0%
Feb 14, 2024
Dec 31, 2023 (Pre market)
0.03 Surprise
  • Reported EPS: $0.25
  • Estimate: $0.22
  • Whisper: —
  • Surprise %: 13.6%
Oct 27, 2023
Sep 30, 2023 (Pre market)
-0.01 Surprise
  • Reported EPS: $0.25
  • Estimate: $0.26
  • Whisper: —
  • Surprise %: -3.9%
Jul 28, 2023
Jun 30, 2023 (Pre market)
-0.01 Surprise
  • Reported EPS: $0.28
  • Estimate: $0.29
  • Whisper: —
  • Surprise %: -3.5%
Apr 28, 2023
Mar 31, 2023 (Pre market)
0.01 Surprise
  • Reported EPS: $0.29
  • Estimate: $0.28
  • Whisper: —
  • Surprise %: 3.6%

Financials